Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trials

24 recruiting

Attention Deficit Hyperactivity Disorder (ADHD) Trials at a Glance

16 actively recruiting trials for attention deficit hyperactivity disorder (adhd) are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Tokyo, Boston, and Cincinnati. Lead sponsors running attention deficit hyperactivity disorder (adhd) studies include Otsuka Pharmaceutical Co., Ltd., Bazelet Nehushtan LtD., and Assistance Publique - Hôpitaux de Paris.

Browse attention deficit hyperactivity disorder (adhd) trials by phase

Treatments under study

About Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trials

Looking for clinical trials for Attention Deficit Hyperactivity Disorder (ADHD)? There are currently 24 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Attention Deficit Hyperactivity Disorder (ADHD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Attention Deficit Hyperactivity Disorder (ADHD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children

Attention Deficit Hyperactivity Disorder (ADHD)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine146 enrolled1 locationNCT07552909
Recruiting
Not Applicable

Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

SleepPhysical ActivityAttention Deficit Hyperactivity Disorder (ADHD)
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.200 enrolled2 locationsNCT06810180
Recruiting
Phase 4

The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

AutismAttention Deficit Hyperactivity Disorder (ADHD)Autism Spectrum Disorder
Gagan Joshi196 enrolled1 locationNCT06853665
Recruiting
Not Applicable

Improving ADHD Teen Driving - Virtual Reality

Attention Deficit Hyperactivity Disorder (ADHD)
Children's Hospital Medical Center, Cincinnati204 enrolled1 locationNCT06960980
Recruiting
Not Applicable

L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASD

Attention Deficit Hyperactivity Disorder (ADHD)Autism Spectrum Disorder (ASD)
Texas Tech University Health Sciences Center24 enrolled1 locationNCT07189442
Recruiting

Prediction of ADHD in Children Using Pedobarographic and Postural Data

Attention Deficit Hyperactivity Disorder (ADHD)
Biruni University100 enrolled1 locationNCT07180758
Recruiting
Phase 2Phase 3

Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients

Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.630 enrolled1 locationNCT06931080
Recruiting
Phase 3

A Long-term Trial of EB-1020 in Adult Patients With ADHD

Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.180 enrolled1 locationNCT06926829
Recruiting
Not Applicable

Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment

Attention Deficit Hyperactivity Disorder (ADHD)Substance-related Disorder
Assistance Publique - Hôpitaux de Paris132 enrolled1 locationNCT06858527
Recruiting
Phase 2

The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD

Attention Deficit Hyperactivity Disorder (ADHD)
Bazelet Nehushtan LtD.120 enrolled1 locationNCT06542445
Recruiting

Quiet Minds for Cardio Kids - Exploring the Effect of Physical Activity on Brain and Psychological Development in Children with and without ADHD

Attention Deficit Hyperactivity Disorder (ADHD)
Deakin University120 enrolled1 locationACTRN12624000517572
Recruiting

The Relationship Between Emotion Regulation and Psychiatric Disorder in Youth

Adjustment DisorderAttention Deficit Hyperactivity Disorder (ADHD)Major Depressive Disorder+1 more
Chang Gung Memorial Hospital200 enrolled1 locationNCT06271954
Recruiting

Improving care of attention deficit hyperactivity disorder (ADHD) in people who use drugs

Attention Deficit Hyperactivity Disorder (ADHD)
Alcohol and Drug Research Innovation Agenda (ADRIA)80 enrolled1 locationACTRN12624000269538
Recruiting

A structural and functional imaging research of children with Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)
Children Psychiatry Department, Institute of Mental Health, Peking University30 enrolled1 locationACTRN12608000059369
Recruiting

Investigation of the effect of a single dose of stimulant medication (dexamphetamine 10mg or methylphenidate 20mg) on appetite and on fasting and postprandial levels of insulin, glucose, leptin and ghrelin in healthy adult volunteers.

Appetite suppression on stimulant medication. This is the presumed reason for the weight loss that usually occurs when children with attention deficit hyperactivity disorder (ADHD) are treated with dexamphetamine or methylphenidate.
Chief investigator Dr Alison Poulton12 enrolled1 locationACTRN12607000138482
Recruiting
Phase 2

An Investigation of Chiropractic NET for Attention Deficit Hyperactivity Disorder in Children.

Attention Deficit Hyperactivity Disorder (ADHD)
Dr Henry Pollard (Primary Supervisor, Director of Research- Dept Health & Chiropractic Macquarie University)93 enrolled1 locationACTRN12606000332527